======= DDX1 ======= == Gene Information == * **Official Symbol**: DDX1 * **Official Name**: DEAD-box helicase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1653|1653]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92499|Q92499]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DDX1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DDX1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601257|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as an ATP-dependent RNA helicase, able to unwind both RNA-RNA and RNA-DNA duplexes. Possesses 5' single-stranded RNA overhang nuclease activity. Possesses ATPase activity on various RNA, but not DNA polynucleotides. May play a role in RNA clearance at DNA double-strand breaks (DSBs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. Together with RELA, acts as a coactivator to enhance NF-kappa-B-mediated transcriptional activation. Acts as a positive transcriptional regulator of cyclin CCND2 expression. Binds to the cyclin CCND2 promoter region. Associates with chromatin at the NF- kappa-B promoter region via association with RELA. Binds to poly(A) RNA. May be involved in 3'-end cleavage and polyadenylation of pre-mRNAs. Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB: together with archease (ZBTB8OS), acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation (PubMed:24870230). {ECO:0000269|PubMed:12183465, ECO:0000269|PubMed:15567440, ECO:0000269|PubMed:18335541, ECO:0000269|PubMed:18710941, ECO:0000269|PubMed:20573827, ECO:0000269|PubMed:24870230}. (Microbial infection) Required for Coronavirus IBV replication. {ECO:0000269|PubMed:20573827}. |SPRY| |DEAD| |Helicase C| |DNA/RNA helicase activity| |cleavage body| |positive regulation of myeloid dendritic cell cytokine production| |regulation of myeloid dendritic cell cytokine production| |positive regulation of dendritic cell cytokine production| |protein localization to cytoplasmic stress granule| |tRNA-splicing ligase complex| |regulation of dendritic cell cytokine production| |nuclease activity| |tRNA splicing, via endonucleolytic cleavage and ligation| |exonuclease activity| |RNA splicing, via endonucleolytic cleavage and ligation| |positive regulation of myeloid leukocyte cytokine production involved in immune response| |poly(A) binding| |positive regulation of myeloid leukocyte mediated immunity| |helicase activity| |response to exogenous dsRNA| |response to dsRNA| |positive regulation of cytokine production involved in immune response| |spliceosomal complex assembly| |regulation of myeloid leukocyte mediated immunity| |RNA helicase activity| |cytoplasmic stress granule| |double-stranded RNA binding| |regulation of translational initiation| |transcription coregulator activity| |regulation of cytokine production involved in immune response| |positive regulation of production of molecular mediator of immune response| |DNA duplex unwinding| |DNA geometric change| |tRNA processing| |positive regulation of leukocyte mediated immunity| |regulation of production of molecular mediator of immune response| |ribonucleoprotein complex| |double-strand break repair| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |tRNA metabolic process| |defense response to virus| |regulation of leukocyte mediated immunity| |positive regulation of immune effector process| |ribonucleoprotein complex assembly| |regulation of I-kappaB kinase/NF-kappaB signaling| |ribonucleoprotein complex subunit organization| |response to virus| |DNA conformation change| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |mRNA splicing, via spliceosome| |nucleic acid phosphodiester bond hydrolysis| |RNA splicing, via transesterification reactions| |regulation of translation| |ncRNA processing| |chromatin binding| |RNA splicing| |regulation of cellular amide metabolic process| |positive regulation of cytokine production| |ribonucleoprotein complex biogenesis| |regulation of immune effector process| |ncRNA metabolic process| |mRNA processing| |DNA repair| |posttranscriptional regulation of gene expression| |regulation of cytokine production| |mRNA metabolic process| |protein localization to organelle| |DNA metabolic process| |innate immune response| |cellular response to DNA damage stimulus| |cellular protein-containing complex assembly| |positive regulation of immune response| |RNA processing| |response to organic cyclic compound| |defense response to other organism| |positive regulation of intracellular signal transduction| |chromosome organization| |response to nitrogen compound| |immune effector process| |positive regulation of immune system process| |regulation of immune response| |mitochondrion| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |RNA binding| |DNA binding| |ATP binding| |protein-containing complex assembly| |cellular protein localization| |cellular macromolecule localization| |regulation of immune system process| |positive regulation of signal transduction| |RNA metabolic process| |cellular response to stress| |positive regulation of multicellular organismal process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |immune response| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.21| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.84| |[[:results:exp93|DABN racemic mixture R03 exp93]]|1.71| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.71| |[[:results:exp19|Etoposide 1μM R00 exp19]]|1.76| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.76| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.87| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|1.88| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|1.91| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|1.94| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|1.94| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|2.01| |[[:results:exp135|MS023 7μM R03 exp135]]|2.14| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.22| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|2.23| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.66| ^Gene^Correlation^ |[[:human genes:t:thg1l|THG1L]]|0.591| |[[:human genes:p:pyroxd1|PYROXD1]]|0.558| |[[:human genes:r:rtcb|RTCB]]|0.552| |[[:human genes:t:tsen34|TSEN34]]|0.55| |[[:human genes:f:fh|FH]]|0.527| |[[:human genes:e:elp2|ELP2]]|0.518| |[[:human genes:a:alg1|ALG1]]|0.506| |[[:human genes:c:c14orf166|C14orf166]]|0.506| |[[:human genes:d:dpagt1|DPAGT1]]|0.504| |[[:human genes:r:rpp21|RPP21]]|0.489| |[[:human genes:d:dolk|DOLK]]|0.487| |[[:human genes:e:elp3|ELP3]]|0.486| |[[:human genes:r:rfk|RFK]]|0.48| |[[:human genes:t:tsen54|TSEN54]]|0.48| |[[:human genes:u:uap1|UAP1]]|0.476| |[[:human genes:v:vezt|VEZT]]|0.474| |[[:human genes:a:atxn10|ATXN10]]|0.473| |[[:human genes:u:urm1|URM1]]|0.471| |[[:human genes:g:gfpt1|GFPT1]]|0.466| |[[:human genes:d:dnlz|DNLZ]]|0.459| |[[:human genes:r:rptor|RPTOR]]|0.458| |[[:human genes:a:alg2|ALG2]]|0.447| |[[:human genes:a:atic|ATIC]]|0.446| |[[:human genes:t:trmt5|TRMT5]]|0.442| |[[:human genes:d:dr1|DR1]]|0.44| |[[:human genes:p:pmm2|PMM2]]|0.436| |[[:human genes:d:dohh|DOHH]]|0.436| |[[:human genes:r:rft1|RFT1]]|0.435| |[[:human genes:g:gnb1l|GNB1L]]|0.434| |[[:human genes:p:ppp6c|PPP6C]]|0.433| |[[:human genes:a:atp5o|ATP5O]]|0.43| |[[:human genes:o:osgep|OSGEP]]|0.429| |[[:human genes:f:fam98b|FAM98B]]|0.427| |[[:human genes:t:tbcb|TBCB]]|0.426| |[[:human genes:s:snapc5|SNAPC5]]|0.425| |[[:human genes:t:tti2|TTI2]]|0.424| |[[:human genes:p:ppp4c|PPP4C]]|0.423| |[[:human genes:s:srp14|SRP14]]|0.423| |[[:human genes:t:triap1|TRIAP1]]|0.421| |[[:human genes:l:lsm11|LSM11]]|0.419| |[[:human genes:e:eef1e1|EEF1E1]]|0.418| |[[:human genes:c:c15orf41|C15orf41]]|0.416| |[[:human genes:g:gemin8|GEMIN8]]|0.416| |[[:human genes:g:gemin6|GEMIN6]]|0.414| |[[:human genes:t:tsen15|TSEN15]]|0.413| |[[:human genes:e:elp6|ELP6]]|0.412| |[[:human genes:t:tprkb|TPRKB]]|0.412| |[[:human genes:a:atp5b|ATP5B]]|0.41| |[[:human genes:n:nae1|NAE1]]|0.409| |[[:human genes:k:kti12|KTI12]]|0.408| |[[:human genes:g:gtf3c4|GTF3C4]]|0.407| |[[:human genes:p:pelo|PELO]]|0.406| |[[:human genes:w:wdr92|WDR92]]|0.406| |[[:human genes:c:ctu1|CTU1]]|0.404| |[[:human genes:p:ppcs|PPCS]]|0.403| |[[:human genes:e:exoc4|EXOC4]]|0.402| |[[:human genes:a:atp2b1|ATP2B1]]|0.401| |[[:human genes:r:rpia|RPIA]]|0.4| |[[:human genes:f:fnta|FNTA]]|0.4| Global Fraction of Cell Lines Where Essential: 11/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|1/14| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|2/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 675 * **Expression level (log2 read counts)**: 7.24 {{:chemogenomics:nalm6 dist.png?nolink |}}